BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang JL, Du XF, Chen SL, Yu YQ, Wang J, Hu XQ, Shao LY, Chen JZ, Weng XH, Zhang WH. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy. World J Gastroenterol 2015; 21(32): 9598-9606 [PMID: 26327767 DOI: 10.3748/wjg.v21.i32.9598]
URL: https://www.wjgnet.com/1948-5182/full/v21/i32/9598.htm
Number Citing Articles
1
Yuanyuan Kong, Tingting Lv, Min Li, Lianghui Zhao, Tongtong Meng, Shanshan Wu, Wei Wei, Qian Zhang, Sha Chen, Hong You, Sabela Lens, Hitoshi Yoshiji, Sven Francque, Emmanouil Tsochatzis, Shiv K. Sarin, Mattias Mandorfer, Jidong Jia. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver diseaseHepatology International 2022; 16(5): 1052 doi: 10.1007/s12072-022-10369-w
2
Guojun Li, Qiran Zhang, Yiqi Yu, Chao Qiu, Hanyue Zhang, Miaoqu Zhang, Zhangzhang Song, Yusheng Yang, Jiemin Hong, Jian Lu, Niuniu Li, Quanzhen Tang, Long Xu, Xuanyi Wang, Wenhong Zhang, Zhi Chen. Histological responses of peginterferon alpha add‐on therapy in patients with chronic hepatitis B with advanced liver fibrosis after long‐term nucleos(t)ide analog treatmentJournal of Viral Hepatitis 2019; 26(S1): 50 doi: 10.1111/jvh.13152
3
E K Ibragimov, D T Abdurakhmanov, T P Rozina, E N Nikulkina, E L Tanaschuk, A V Odintsov, S V Panevkina, S V Moiseev. Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis BTerapevticheskii arkhiv 2019; 91(2): 40 doi: 10.26442/00403660.2019.02.000073
4
Gautam Ray. 5-year efficacy of entecavir in Indian patients with chronic hepatitis BIndian Journal of Gastroenterology 2016; 35(3): 190 doi: 10.1007/s12664-016-0664-x
5
Qian Zhang, Da-Chuan Cai, Peng Hu, Hong Ren. Low-level viremia in nucleoside analog-treated chronic hepatitis B patientsChinese Medical Journal 2021; 134(23): 2810 doi: 10.1097/CM9.0000000000001793
6
Sung Won Lee, Sung Min Kim, Wonhee Hur, Byung-Yoon Kang, Hae Lim Lee, Heechul Nam, Sun Hong Yoo, Pil Soo Sung, Jung Hyun Kwon, Jeong Won Jang, Seong-Jun Kim, Seung Kew Yoon, Partha Mukhopadhyay. Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathwayPLOS ONE 2021; 16(12): e0261067 doi: 10.1371/journal.pone.0261067
7
Trung Doan Hieu, Chuong Tran Xuan. LIVER FIBROSIS RESPONSE TO ENTECAVIR TREATMENT IN PATIENTS WITH HBV-RELATED COMPENSATED CIRRHOSISJournal of Medicine and Pharmacy 2018; 8(6): 203 doi: 10.34071/jmp.2018.6.27
8
Emmanuel Thomas, T. Jake Liang. Experimental models of hepatitis B and C — new insights and progressNature Reviews Gastroenterology & Hepatology 2016; 13(6): 362 doi: 10.1038/nrgastro.2016.37
9
Tao Du, Bing Yu, Wei Luo. Liver cirrhosis reversal and recompensation: Existing evidence and future prospectsWorld Chinese Journal of Digestology 2024; 32(5): 320 doi: 10.11569/wcjd.v32.i5.320
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
10
Xiao-Dong Gai, Wei-Feng Wu. Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosisExperimental and Therapeutic Medicine 2017; 14(4): 3908 doi: 10.3892/etm.2017.4963
11
Maria Guido. Practical Hepatic Pathology: a Diagnostic Approach2018; : 671 doi: 10.1016/B978-0-323-42873-6.00040-8
12
Gang Qin, Jian-Guo Shao, Yong-Chang Zhu, Ai-Dong Xu, Jian-Hua Yao, Xu-Lin Wang, Yin-Kun Qian, Hua-Yu Wang, Yi Shen, Peng Lu, Lu-Jun Wang. Population-representative Incidence of Acute-On-Chronic Liver FailureJournal of Clinical Gastroenterology 2016; 50(8): 670 doi: 10.1097/MCG.0000000000000538
13
Jing Wang, Yiqi Yu, Guojun Li, Chuan Shen, Zhefeng Meng, Jianming Zheng, Yanhong Jia, Shaolong Chen, Xiao Zhang, Mengqi Zhu, Jiangjiang Zheng, Zhangzhang Song, Jing Wu, Lingyun Shao, Peiyu Qian, Xiaona Mao, Xuanyi Wang, Yuxian Huang, Caiyan Zhao, Jiming Zhang, Chao Qiu, Wenhong Zhang. Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patientsJournal of Hepatology 2018; 68(1): 16 doi: 10.1016/j.jhep.2017.08.021
14
Min-Ran Li, Huan-Wei Zheng, Shun-Mao Ma, Yun-Yan Liu, Lan-Xia Qie, Jun-Qing Li, De-Hua Wang, Xing-Li Sun, Gui-Fang Ren, Yan-Hua Zheng, Yu-Ling Wang, Er-Hei Dai. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patientsJournal of the Chinese Medical Association 2018; 81(12): 1052 doi: 10.1016/j.jcma.2018.05.007
15
Qiran Zhang, Guojun Li, Yiqi Yu, Chao Qiu, Jianming Zheng, Hanyue Zhang, Miaoqu Zhang, Zhangzhang Song, Yusheng Yang, Xinfang Du, Jiemin Hong, Jian Lu, Niuniu Li, Quanzhen Tang, Long Xu, Xuanyi Wang, Yuxian Huang, Jiming Zhang, Zhi Chen, Wenhong Zhang. Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment‐naïve chronic hepatitis B patientsJournal of Viral Hepatitis 2019; 26(S1): 59 doi: 10.1111/jvh.13153